Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumi Higuchi

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Acta Neuropathologica Communications|November 24, 2020
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutationsHideyuki Arita, Yuko Matsushita, Ryunosuke Machida, et al.
Acta Neuropathologica|January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutationSina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Acta Neuropathologica Communications|November 24, 2020
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutationsHideyuki Arita, Yuko Matsushita, Ryunosuke Machida, et al.
Acta Neuropathologica|January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutationSina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Pageof 4